Endocrine abnormalities induced by the antiviral drugs and frequency of their occurrence

Pol Merkur Lekarski. 2020 Jun 17;48(285):209-214.

Abstract

Viral infections lead to many disorders with a different course and prognosis. Clinical trials are ongoing on new groups of antiviral drugs, which are very promising. However, treatment with antiviral drugs causes numerous adverse effects (AEs) including hormonal dysfunctions. The aim of this article is to discuss endocrine abnormalities induced by the antiviral drugs including frequency of their occurrence. The review is based on the available literature in the Medline database and considers the latest articles describing endocrine disorders with relation to antiviral therapy. The hormonal and metabolic dysfunctions were discussed, including the AEs like: osteoporosis, osteomalacia, hypoand hyperthyroidism, metabolic syndrome, lipodystrophy, hyperglycemia, diabetes mellitus and others. Awareness of frequency and type of complications caused by antiviral drugs, enables faster linking of the disease with the therapy, so it allows the personalization of treatment. It's necessary to monitor the general condition of the patients and appropriate diagnostic parameters that it can help diagnose hormonal disorders and adjust an individual antiviral therapy for the patient with endocrinopathy.

Keywords: antiviral drugs; endocrine disorders.

Publication types

  • Review

MeSH terms

  • Antiviral Agents* / adverse effects
  • Diabetes Mellitus* / chemically induced
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Hyperglycemia* / chemically induced
  • Osteoporosis* / chemically induced

Substances

  • Antiviral Agents